Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Abstract

Elastography as a Method for the Detection of Breast Cancer

Juan Farak Gomez*, Andres Felipe Diaz Munoz, Heyman Bravo Dominguez, Maria Carolina Causil Galvis, Sarly Katiana Serrano Medina, Lilian Paola Navarro Mercado, Diana Carolina Gonzalez Sotelo, David Alejandro Guzman Sanchez, Irina Alejandra Vallejos Diaz and Juan Abraham Gonzales Albarracin

Breast cancer is a disease characterized by the increase and lack of control in the growth of mammary epithelial cells. In recent years, research has been carried out on new technologies with the aim of being more precise and less radical in the methods used for the diagnosis of breast cancer, where a new use of ultrasound based on the properties of elastic tissues emerged, a technology that uses the name of elastography, which greatly improves the accuracy of diagnosis, the development and application of elastography in the breast, it has made it possible to characterize the elasticity of lesions detected by B-mode (fundamentally nodules) and in certain cases to raise or lower the degree of suspicion of lesions initially assessed by B-mode and color doppler, for breast cancer, has been shown that elastic ultrasound provides information on prognosis and response to neo adjuvant therapy, considering that cancer breast is a heterogeneous disease. Prognostic factors are represented by histological type, tumor size, histological grade, axillary lymph node metastasis and lymphatic vascular invasion, considering the above, when using this technique for early diagnosis, assess prognosis and grade of malignancy of the patients, thus achieving timely treatment which will allow a decrease in the morbidity and mortality of these patients.

Published Date: 2023-09-29; Received Date: 2022-04-21